Work

Decreased nasal polyp eosinophils but increased mast cells in a patient with aspirin-exacerbated respiratory disease treated with reslizumab

Year: 2020

Type: article

Source: Annals of Allergy Asthma & Immunology

DOI: 10.1016/j.anai.2020.06.043

Authors: Anna G. Staudacher, Anju T. Peters, Roderick G. Carter, Kevin C. Welch, Whitney W. Stevens

Institution: Northwestern University

Language: English

Topic: Sinusitis and nasal conditions

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Academy of Allergy Asthma and Immunology, University of Arizona Cancer Center, American Partnership for Eosinophilic Disorders, National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences

Awards: G2322867738, Northwestern University Clinical and Translational Science Institute (NUCATS), Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2), Chronic Rhinosinusitis Integrative Studies Program (CRISP), Cellular and Molecular Mechanisms of the Pathogenesis of Aspirin Exacerbated Respiratory Disease, G630735843, Initiators, biomarkers and mechanisms of epithelial dysfunction and immune pathogenesis in chronic rhinosinusitis and aspirin exacerbated respiratory disease (AERD)

OpenAlex ID: W3039250391

FWCI: 0.805

Cites: 18

Cited by: 7

Related to: 10